TABLE 2.
V50 (mV) | k | |
Control | −0.1 ± 5.4 | −32.6 ± 9.2 |
5μM AL | 0.8 ± 5.2 | −36.4 ± 8.3 |
TTX | −9.5 ± 9.4 | −29.8 ± 4.9 |
TTX + AL | −9.8 ± 5.5 | −31.2 ± 6.3 |
GVIA | 40.4 ± 10.3a | −40.6 ± 17.3 |
GVIA + AL | −1.0 ± 7.4b | −45.3 ± 9.6 |
NIM | −13.4 ± 2.4 | −27.8 ± 2.6 |
NIM + AL | −11.6 ± 3.9 | −20.2 ± 5.0 |
Note. Parameters were estimated using the Boltzman equation (I/Imax = 1/(1 + e−(V − V50)/k)), where V50 is the half-inactivation voltage and k is a measure of steepness. No significant differences were observed within treatments, except that cells exposed to both GVIA and AL exhibited inactivation at a significantly more negative potential than cells exposed to GVIA alone.
Extrapolated V50 of inactivation, as full inactivation is likely only theoretical under these conditions. Values are reported as the mean ± SEM, n = 5–7 cells per condition.
Significance from GVIA-treated cells (p < 0.05, paired t-test).